| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.44 | 4e-16 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-13 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.38 | 3e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.27 | 5e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 6e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-06 |